• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计一种变构调节的强力霉素和阿霉素药物结合蛋白。

Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein.

机构信息

Department of Biotechnology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.

Single-Molecule Microscopy Group, Jena University Hospital, Friedrich-Schiller University Jena, 07743 Jena, Germany.

出版信息

Proc Natl Acad Sci U S A. 2018 May 29;115(22):5744-5749. doi: 10.1073/pnas.1716666115. Epub 2018 May 14.

DOI:10.1073/pnas.1716666115
PMID:29760101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5984491/
Abstract

The allosteric interplay between distant functional sites present in a single protein provides for one of the most important regulatory mechanisms in biological systems. While the design of ligand-binding sites into proteins remains challenging, this holds even truer for the coupling of a newly engineered binding site to an allosteric mechanism that regulates the ligand affinity. Here it is shown how computational design algorithms enabled the introduction of doxycycline- and doxorubicin-binding sites into the serine proteinase inhibitor (serpin) family member α1-antichymotrypsin. Further engineering allowed exploitation of the proteinase-triggered serpin-typical S-to-R transition to modulate the ligand affinities. These design variants follow strategies observed in naturally occurring plasma globulins that allow for the targeted delivery of hormones in the blood. By analogy, we propose that the variants described in the present study could be further developed to allow for the delivery of the antibiotic doxycycline and the anticancer compound doxorubicin to tissues/locations that express specific proteinases, such as bacterial infection sites or tumor cells secreting matrix metalloproteinases.

摘要

在单个蛋白质中存在的远距离功能位点的变构相互作用提供了生物系统中最重要的调节机制之一。虽然将配体结合位点设计到蛋白质中仍然具有挑战性,但对于将新设计的结合位点与调节配体亲和力的变构机制相耦合来说,更是如此。本文展示了如何使用计算设计算法将强力霉素和阿霉素结合位点引入丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂)家族成员α1-抗胰蛋白酶。进一步的工程设计允许利用蛋白酶触发的丝氨酸蛋白酶典型的 S 到 R 转变来调节配体亲和力。这些设计变体遵循在天然存在的血浆球蛋白中观察到的策略,允许在血液中靶向递送激素。通过类比,我们提出在本研究中描述的变体可以进一步开发,以允许将抗生素强力霉素和抗癌化合物阿霉素递送至表达特定蛋白酶的组织/位置,例如细菌感染部位或分泌基质金属蛋白酶的肿瘤细胞。

相似文献

1
Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein.设计一种变构调节的强力霉素和阿霉素药物结合蛋白。
Proc Natl Acad Sci U S A. 2018 May 29;115(22):5744-5749. doi: 10.1073/pnas.1716666115. Epub 2018 May 14.
2
NewBG: A surrogate corticosteroid-binding globulin with an unprecedentedly high ligand release efficacy.新 BCG:一种具有空前高配体释放效率的替代皮质类固醇结合球蛋白。
J Struct Biol. 2019 Aug 1;207(2):169-182. doi: 10.1016/j.jsb.2019.05.006. Epub 2019 May 16.
3
Role of the P2 residue in determining the specificity of serpins.P2残基在决定丝氨酸蛋白酶抑制剂特异性中的作用。
Biochemistry. 1996 Sep 3;35(35):11461-9. doi: 10.1021/bi952717i.
4
Distortion of the active site of chymotrypsin complexed with a serpin.与丝氨酸蛋白酶抑制剂复合的胰凝乳蛋白酶活性位点的扭曲。
Biochemistry. 1996 Jun 11;35(23):7586-90. doi: 10.1021/bi960233w.
5
Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.通过比较模型构建对α-1-抗糜蛋白酶:前列腺特异性抗原复合物进行结构研究。
Protein Sci. 1996 May;5(5):836-51. doi: 10.1002/pro.5560050505.
6
Role of Lys335 in the metastability and function of inhibitory serpins.赖氨酸335在抑制性丝氨酸蛋白酶抑制剂的亚稳定性和功能中的作用。
Protein Sci. 2000 May;9(5):934-41. doi: 10.1110/ps.9.5.934.
7
Design and characterization of a novel human Granzyme B inhibitor.一种新型人颗粒酶B抑制剂的设计与表征
Protein Eng Des Sel. 2015 Jan;28(1):9-17. doi: 10.1093/protein/gzu052. Epub 2014 Dec 9.
8
Engineering allosteric regulation into the hinge region of a circularly permuted TEM-1 beta-lactamase.将别构调节工程引入环化重排 TEM-1 β-内酰胺酶的铰链区。
Protein Eng Des Sel. 2010 Sep;23(9):699-709. doi: 10.1093/protein/gzq041. Epub 2010 Jun 30.
9
Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema.潜伏性α1-抗糜蛋白酶。慢性支气管炎和肺气肿中α1-抗糜蛋白酶失活的分子解释。
J Biol Chem. 1998 Feb 6;273(6):3695-701. doi: 10.1074/jbc.273.6.3695.
10
Binding of alpha1-antichymotrypsin to the surface of lymphocytes--preliminary study.α1-抗糜蛋白酶与淋巴细胞表面的结合——初步研究。
Rocz Akad Med Bialymst. 2005;50:325-8.

引用本文的文献

1
Unlocking Nature's Potential: Ferritin as a Universal Nanocarrier for Amplified Cancer Therapy Testing via 3D Microtissues.释放自然潜能:铁蛋白作为通过三维微组织进行增强型癌症治疗测试的通用纳米载体
ACS Appl Mater Interfaces. 2024 Dec 25;16(51):70187-70204. doi: 10.1021/acsami.4c12524. Epub 2024 Dec 11.
2
De novo prediction of explicit water molecule positions by a novel algorithm within the protein design software MUMBO.利用蛋白质设计软件 MUMBO 中的一种新算法从头预测明确的水分子位置。
Sci Rep. 2023 Oct 4;13(1):16680. doi: 10.1038/s41598-023-43659-w.
3
Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells.负载阿霉素的铁蛋白纳米颗粒用于铁死亡增强对癌细胞的靶向杀伤
RSC Adv. 2019 Sep 10;9(49):28548-28553. doi: 10.1039/c9ra04478g. eCollection 2019 Sep 9.
4
Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases.α1-抗糜蛋白酶作为人类疾病诊断、预后及治疗预测的新型生物标志物。
Cancer Cell Int. 2022 Apr 19;22(1):156. doi: 10.1186/s12935-022-02572-4.
5
Biological Profile of Two L. Metabolites Using Computational Approaches and In Vitro Tests.采用计算方法和体外试验研究两种 L. 代谢产物的生物学特性。
Biomolecules. 2021 Oct 9;11(10):1490. doi: 10.3390/biom11101490.
6
Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against in an Model.多西环素在[具体模型名称未给出]模型中对[未提及的对象]的药代动力学/药效学整合
Front Pharmacol. 2019 Sep 20;10:1088. doi: 10.3389/fphar.2019.01088. eCollection 2019.

本文引用的文献

1
Conformational dynamics of the rotary subunit F in the A B DF complex of Methanosarcina mazei Gö1 A-ATP synthase monitored by single-molecule FRET.通过单分子荧光共振能量转移监测马氏甲烷八叠球菌Gö1 A型ATP合酶ABDF复合物中旋转亚基F的构象动力学。
FEBS Lett. 2017 Mar;591(6):854-862. doi: 10.1002/1873-3468.12605. Epub 2017 Mar 10.
2
Principles for designing proteins with cavities formed by curved β sheets.设计由弯曲β折叠形成空洞的蛋白质的原则。
Science. 2017 Jan 13;355(6321):201-206. doi: 10.1126/science.aah7389.
3
Cortisol and CBG - Getting cortisol to the right place at the right time.皮质醇和大麻素 - 让皮质醇在正确的时间到达正确的位置。
Pharmacol Ther. 2016 Oct;166:128-35. doi: 10.1016/j.pharmthera.2016.06.020. Epub 2016 Jul 10.
4
Designer protein delivery: From natural to engineered affinity-controlled release systems.设计蛋白递释系统:从天然到工程化的亲和控制释放系统。
Science. 2016 Mar 18;351(6279):aac4750. doi: 10.1126/science.aac4750.
5
Engineering an allosteric transcription factor to respond to new ligands.设计一种变构转录因子以响应新的配体。
Nat Methods. 2016 Feb;13(2):177-83. doi: 10.1038/nmeth.3696. Epub 2015 Dec 21.
6
Towards engineering hormone-binding globulins as drug delivery agents.致力于将激素结合球蛋白工程化为药物递送剂。
PLoS One. 2014 Nov 26;9(11):e113402. doi: 10.1371/journal.pone.0113402. eCollection 2014.
7
A unified view of "how allostery works".关于“变构作用如何发挥”的统一观点。
PLoS Comput Biol. 2014 Feb 6;10(2):e1003394. doi: 10.1371/journal.pcbi.1003394. eCollection 2014 Feb.
8
Computational protein design of ligand binding and catalysis.配体结合和催化的计算蛋白质设计。
Curr Opin Chem Biol. 2013 Dec;17(6):929-33. doi: 10.1016/j.cbpa.2013.10.002.
9
SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.SIRT1 和 AMPK 介导低氧诱导非小细胞肺癌对顺铂和阿霉素的耐药性。
Cancer Res. 2014 Jan 1;74(1):298-308. doi: 10.1158/0008-5472.CAN-13-2620. Epub 2013 Nov 15.
10
Computational design of ligand-binding proteins with high affinity and selectivity.具有高亲和力和选择性的配体结合蛋白的计算设计。
Nature. 2013 Sep 12;501(7466):212-216. doi: 10.1038/nature12443. Epub 2013 Sep 4.